Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients

Citrullinated neoepitopes have emerged as key triggers of autoantibodies anti-citrullinated protein antibodies (ACPA) synthesis in rheumatoid arthritis (RA) patients. Apart from their critical role in homeostasis and thrombosis, platelets have a significant contribution to inflammation as well. Alth...

Full description

Bibliographic Details
Main Authors: Minjie Xu, Rong Du, Wenping Xing, Xueting Chen, Jian Wan, Shengqing Wang, Li Xiong, Kutty Selva Nandakumar, Rikard Holmdahl, Hui Geng
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1084283/full
_version_ 1797944855183228928
author Minjie Xu
Rong Du
Wenping Xing
Xueting Chen
Jian Wan
Shengqing Wang
Li Xiong
Kutty Selva Nandakumar
Rikard Holmdahl
Hui Geng
author_facet Minjie Xu
Rong Du
Wenping Xing
Xueting Chen
Jian Wan
Shengqing Wang
Li Xiong
Kutty Selva Nandakumar
Rikard Holmdahl
Hui Geng
author_sort Minjie Xu
collection DOAJ
description Citrullinated neoepitopes have emerged as key triggers of autoantibodies anti-citrullinated protein antibodies (ACPA) synthesis in rheumatoid arthritis (RA) patients. Apart from their critical role in homeostasis and thrombosis, platelets have a significant contribution to inflammation as well. Although anuclear in nature, platelets have an intricate post-translational modification machinery. Till now, citrullination in platelets and its contribution to trigger autoantibodies ACPA production in RA is an unexplored research direction. Herein, we investigated the expression of peptidylarginine deiminase (PAD) enzymes and citrullinated proteins/peptides in the human platelets and platelet derived microparticles (PDP). Both PAD4 mRNA and protein, but not the other PAD isoforms, are detectable in the human platelets. With a strict filtering criterion,108 citrullination sites present on 76 proteins were identified in the human platelets, and 55 citrullinated modifications present on 37 different proteins were detected in the PDPs. Among them, some are well-known citrullinated autoantigens associated with RA. Citrullinated forms of thrombospondin-1, β-actin, and platelet factor-4 (also known as CXCL4) are highly immunogenic and bound by autoantibodies ACPA. Furthermore, ACPA from RA sera and synovial fluids recognized citrullinated proteins from platelets and significantly activated them as evidenced by P-selectin upregulation and sCD40 L secretion. These results clearly demonstrate the presence of citrullinated autoantigens in platelets and PDPs, thus could serve as potential targets of ACPA in RA.
first_indexed 2024-04-10T20:46:14Z
format Article
id doaj.art-beda157e5b934232b808e9ed957c18f0
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-10T20:46:14Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-beda157e5b934232b808e9ed957c18f02023-01-24T07:55:24ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-01-011410.3389/fimmu.2023.10842831084283Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patientsMinjie Xu0Rong Du1Wenping Xing2Xueting Chen3Jian Wan4Shengqing Wang5Li Xiong6Kutty Selva Nandakumar7Rikard Holmdahl8Hui Geng9Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan, ChinaDepartment of Rheumatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaHubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan, ChinaHubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan, ChinaHubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan, ChinaDepartment of Dermatology, Hospital affiliated to Central China Normal University, Wuhan, ChinaHubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan, ChinaDepartment of Environmental and Biosciences, School of Business, Innovation and Sustainability, Halmstad University, Halmstad, SwedenDivision of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, SwedenHubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan, ChinaCitrullinated neoepitopes have emerged as key triggers of autoantibodies anti-citrullinated protein antibodies (ACPA) synthesis in rheumatoid arthritis (RA) patients. Apart from their critical role in homeostasis and thrombosis, platelets have a significant contribution to inflammation as well. Although anuclear in nature, platelets have an intricate post-translational modification machinery. Till now, citrullination in platelets and its contribution to trigger autoantibodies ACPA production in RA is an unexplored research direction. Herein, we investigated the expression of peptidylarginine deiminase (PAD) enzymes and citrullinated proteins/peptides in the human platelets and platelet derived microparticles (PDP). Both PAD4 mRNA and protein, but not the other PAD isoforms, are detectable in the human platelets. With a strict filtering criterion,108 citrullination sites present on 76 proteins were identified in the human platelets, and 55 citrullinated modifications present on 37 different proteins were detected in the PDPs. Among them, some are well-known citrullinated autoantigens associated with RA. Citrullinated forms of thrombospondin-1, β-actin, and platelet factor-4 (also known as CXCL4) are highly immunogenic and bound by autoantibodies ACPA. Furthermore, ACPA from RA sera and synovial fluids recognized citrullinated proteins from platelets and significantly activated them as evidenced by P-selectin upregulation and sCD40 L secretion. These results clearly demonstrate the presence of citrullinated autoantigens in platelets and PDPs, thus could serve as potential targets of ACPA in RA.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1084283/fullrheumatoid arthritiscitrullinationplateletsanti-citrullinated protein antibodies (ACPA)platelet derived microparticles (PDP)
spellingShingle Minjie Xu
Rong Du
Wenping Xing
Xueting Chen
Jian Wan
Shengqing Wang
Li Xiong
Kutty Selva Nandakumar
Rikard Holmdahl
Hui Geng
Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients
Frontiers in Immunology
rheumatoid arthritis
citrullination
platelets
anti-citrullinated protein antibodies (ACPA)
platelet derived microparticles (PDP)
title Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients
title_full Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients
title_fullStr Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients
title_full_unstemmed Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients
title_short Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients
title_sort platelets derived citrullinated proteins and microparticles are potential autoantibodies acpa targets in ra patients
topic rheumatoid arthritis
citrullination
platelets
anti-citrullinated protein antibodies (ACPA)
platelet derived microparticles (PDP)
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1084283/full
work_keys_str_mv AT minjiexu plateletsderivedcitrullinatedproteinsandmicroparticlesarepotentialautoantibodiesacpatargetsinrapatients
AT rongdu plateletsderivedcitrullinatedproteinsandmicroparticlesarepotentialautoantibodiesacpatargetsinrapatients
AT wenpingxing plateletsderivedcitrullinatedproteinsandmicroparticlesarepotentialautoantibodiesacpatargetsinrapatients
AT xuetingchen plateletsderivedcitrullinatedproteinsandmicroparticlesarepotentialautoantibodiesacpatargetsinrapatients
AT jianwan plateletsderivedcitrullinatedproteinsandmicroparticlesarepotentialautoantibodiesacpatargetsinrapatients
AT shengqingwang plateletsderivedcitrullinatedproteinsandmicroparticlesarepotentialautoantibodiesacpatargetsinrapatients
AT lixiong plateletsderivedcitrullinatedproteinsandmicroparticlesarepotentialautoantibodiesacpatargetsinrapatients
AT kuttyselvanandakumar plateletsderivedcitrullinatedproteinsandmicroparticlesarepotentialautoantibodiesacpatargetsinrapatients
AT rikardholmdahl plateletsderivedcitrullinatedproteinsandmicroparticlesarepotentialautoantibodiesacpatargetsinrapatients
AT huigeng plateletsderivedcitrullinatedproteinsandmicroparticlesarepotentialautoantibodiesacpatargetsinrapatients